Split Personality: How a Divided Congress May Hit Banks, Tech & Pharma
557 views · Published 6 November 2018 · 4:05 · Indexed 26 October 2026
Channel: Bloomberg Television · 2018 · News & Politics
Nov.05 -- With a divided U.S. Congress, analysts think bank and pharmaceutical stocks could come out relatively unharmed, or even supported, if Democrats cause gridlock with Donald Trump's agenda. But the pain could continue for tech and industrials as privacy concerns and trade wars may not go away soon. Ramy Inocencio explains on "Bloomberg Daybreak: Asia."
More from this channel
-
2:16
Economic Policy Institute's Bivens Says Criticism of Tariffs Is Warranted
-
3:02
Blanchflower Says Raising Rates 'Is a Fundamental Mistake'
-
2:57
BlackRock's Rieder Says It's a Risk-Off Environment
-
2:04
How Weather Impacted U.S. Job Creation in March
-
2:32
Millennials Are Finding Jobs, Just Not the Ones They Want
-
1:06
Powell Says Gradual Rate Hikes Best Promote the Fed's Goals
-
0:58
Powell Says Wage Growth Shows Job Market Not 'Excessively Tight'
-
2:17
Quad Capital's Borish Sees More Whiplash in Markets